China’s Experimental Kovid-19 Vaccine Costs $ 60 | The Express Tribune
A Chinese city is offering Synovac Biotech’s experimental Kovid-19 vaccine to essential workers and other high-risk groups as part of a national program for about $ 60.
The eastern city of Jiaxing’s Center for Disease Control and Prevention (CDC) said in a statement on WeChat that two doses of a vaccine candidate named Coronavac, 200 yuan ($ 29.75) per dose, and the vaccination of key groups, including medical professionals, would cost. started.
Chinese authorities do not have to release pricing details for potential Kovid-19 vaccines. Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency vaccination program launched in July.
It was not clear whether the subsidy was included in the pricing of Jiaxing city. The city’s CDC declined to comment.
Synovac did not immediately respond to a request for comment. Its vaccine is in late-stage trials in Brazil, Indonesia and Turkey, and the company said an interim analysis of phase three trial data could come in early November.
State-owned company Bio Pharma in Indonesia, which has reached out to Synovac for a deal for at least 40 million doses, said the vaccine would cost around 200,000 rupees ($ 13.60) per dose this week when it went to the Southeast. Will be available in the Asian country.
China has stated that while fair profits are allowed for companies, the price of Kovid-19 vaccines should be around-the-clock.
The China National Pharmaceutical Group (Sinopharm) said in August that a vaccine candidate developed by a unit could cost no more than 1,000 yuan ($ 148.80) for two shots. An official of China’s National Health Commission has said, however, the price will be lower.